The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic testing offerings in the US.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback